We are live on ! Find out more
Macquarie Group

Macquarie Group Portfolio holdings

AUM $16.8B
1-Year Est. Return 27.39%
This Fund
S&P 500
This Quarter Est. Return
+22.75%
1 Year Est. Return
+27.39%
3 Year Est. Return
+81.07%
5 Year Est. Return
+109.03%
10 Year Est. Return
+396.55%
AUM
$68.5B
AUM Growth
+$9.41B
Cap. Flow
-$1.48B
Cap. Flow %
-2.16%
Top 10 Hldgs %
11.5%
Holding
2,417
New
97
Increased
651
Reduced
820
Closed
64

Top Sells

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$694M
2
BNY
Bank of New York Mellon
BNY
+$668M
3
MRSH
Marsh
MRSH
+$609M
4
DIS icon
Walt Disney
DIS
+$140M
5
TFC icon
Truist Financial
TFC
+$128M

Sector Composition

Rank Sector Weight
1 Technology 18.62%
2 Healthcare 15.47%
3 Financials 13.03%
4 Industrials 11.38%
5 Consumer Discretionary 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DOV icon
551
Dover
DOV
$27.7B
$18M 0.03%
142,448
-12,720
-8% -$1.51M
CPT icon
552
Camden Property Trust
CPT
$11.2B
$18M 0.03%
179,956
-76,849
-30% -$7.44M
WEC icon
553
WEC Energy
WEC
$37.1B
$18M 0.03%
195,206
-40,588
-17% -$3.95M
AIZ icon
554
Assurant
AIZ
$13.7B
$17.9M 0.03%
131,624
-60,308
-31% -$7.8M
DLB icon
555
Dolby
DLB
$4.85B
$17.8M 0.03%
182,907
+179,772
+5,734% +$14.8M
PBR icon
556
Petrobras
PBR
$116B
$17.7M 0.03%
1,576,920
-142,591
-8% -$1.26M
AVNT icon
557
Avient
AVNT
$3.34B
$17.7M 0.03%
439,488
+435,400
+10,651% +$15.3M
SGI
558
Somnigroup International
SGI
$15.3B
$17.7M 0.03%
654,608
-52,244
-7% -$1.27M
SFIX
559
Stitch Fix
SFIX
$536M
$17.6M 0.03%
299,946
-328,540
-52% -$14.1M
BCO icon
560
Brink's
BCO
$4.86B
$17.5M 0.03%
242,947
-18,500
-7% -$1.08M
ICPT
561
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$17.4M 0.03%
704,684
-74,275
-10% -$2.46M
NVRO
562
DELISTED
NEVRO CORP.
NVRO
$17.4M 0.03%
100,496
+16,609
+20% +$2.69M
VFC icon
563
VF Corp
VFC
$6.72B
$17.4M 0.03%
203,408
-54,784
-21% -$4.38M
STE icon
564
Steris
STE
$21.3B
$17.3M 0.03%
91,388
-24,372
-21% -$4.55M
ESS icon
565
Essex Property Trust
ESS
$18.7B
$17.2M 0.03%
72,615
+4,299
+6% +$992K
NIU
566
Niu Technologies
NIU
$209M
$17.2M 0.03%
+612,981
New +$17.8M
WRK
567
DELISTED
WestRock Company
WRK
$17.2M 0.03%
394,731
-166,502
-30% -$6.87M
DQ
568
Daqo New Energy
DQ
$815M
$17.1M 0.03%
298,845
+111,120
+59% +$4.84M
APD icon
569
Air Products & Chemicals
APD
$65.2B
$17.1M 0.03%
62,688
+8,825
+16% +$2.49M
BIIB icon
570
Biogen
BIIB
$29.5B
$17.1M 0.03%
69,787
-706
-1% -$182K
GM icon
571
General Motors
GM
$78.7B
$17M 0.02%
409,388
+197,718
+93% +$7.69M
DOW icon
572
Dow Inc
DOW
$20.8B
$17M 0.02%
306,952
+186,500
+155% +$9.63M
SGEN
573
DELISTED
Seagen Inc. Common Stock
SGEN
$17M 0.02%
97,272
+845
+0.9% +$158K
ZEN
574
DELISTED
ZENDESK INC
ZEN
$17M 0.02%
118,802
-284
-0.2% -$35.2K
SAIL
575
DELISTED
SailPoint Technologies Holdings, Inc. Common Stock
SAIL
$17M 0.02%
319,189
-19,291
-6% -$904K

Similar funds

Macquarie Group's Q4 2020 Portfolio in Review

As of Q4 2020, Macquarie Group held 2,417 positions worth $68.5B, up 16% from $59.1B the previous quarter. Its ten largest holdings account for 11% of the portfolio.

Macquarie Group's Q4 2020 filing shows 97 new, 651 increased, 820 reduced and 64 closed positions. Its largest new stake was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M. The largest sale was Pfizer, an estimated $694M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Financials.

  • Macquarie Group's largest Q4 2020 buy was iShares Core S&P Total US Stock Market ETF: 1,556,025 shares worth $134M.
  • Macquarie Group added most to Discover Financial Services in Q4 2020, an estimated $613M increase.
  • Macquarie Group's biggest Q4 2020 reduction was Pfizer, cutting an estimated $694M.
  • Macquarie Group fully exited MyoKardia, Inc. Common Stock in Q4 2020, selling an estimated $64.8M.
  • Macquarie Group's ten largest holdings make up 11% of its $68.5B portfolio in Q4 2020.
  • Macquarie Group opened 97 new positions and closed 64 in Q4 2020.
  • Macquarie Group's portfolio value rose 16% quarter-over-quarter to $68.5B.

Based on Macquarie Group's 13F filing for Q4 2020, filed 16 Feb 2021.